An HIV-1 antibody from at the very top neutralizer implicates the synthesis peptide as a niche site of vulnerability
Affiliations
- 1 section of health Microbiology, educational Medical Center, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
- 2 section of Immunology and Microbial medicine, Scripps CHAVI-ID, IAVI Neutralizing Antibody heart and relationship for AID Vaccine development (CAVD), The Scripps Studies Institute, La Jolla, Ca 92037, USA.